Id |
Subject |
Object |
Predicate |
Lexical cue |
T96 |
0-156 |
Sentence |
denotes |
Most acute viral infections induce proliferation and activation of CD8 T cells detectable by increases in KI67 or co-expression of CD38 and HLA-DR (34, 35). |
T97 |
157-303 |
Sentence |
denotes |
There was a significant increase in KI67+ and also HLA-DR+CD38+ non-naïve CD8 T cells in COVID-19 patients compared to HD or RD (Fig. 2, E and F). |
T98 |
304-458 |
Sentence |
denotes |
In COVID-19 patients, KI67+ CD8 T cells were increased compared to HD and RD across all subsets of non-naïve CD8 T cells, including CM and EM1 (fig. S2B). |
T99 |
459-651 |
Sentence |
denotes |
These data indicate broad T cell activation, potentially driven by bystander activation and/or homeostatic proliferation in addition to antigen-driven activation of virus-specific CD8 T cells. |
T100 |
652-818 |
Sentence |
denotes |
This activation phenotype was confirmed by HLA-DR and CD38 co-expression that was significantly increased for all non-naïve CD8 T cell subsets (Fig. 2F and fig. S2C). |
T101 |
819-912 |
Sentence |
denotes |
However, the magnitude of the KI67+ or CD38+HLA-DR+ CD8 T cells varied widely in this cohort. |
T102 |
913-1017 |
Sentence |
denotes |
The frequency of KI67+ CD8 T cells correlated with the frequency of CD38+HLA-DR+ CD8 T cells (fig. S2D). |
T103 |
1018-1263 |
Sentence |
denotes |
However, the frequency of CD38+HLA-DR+, but not KI67+ CD8 T cells, was elevated in COVID-19 patients who had concomitant infection with another microbe but was not impacted by pre-existing immunosuppression or treatment with steroids (fig. S2E). |
T104 |
1264-1529 |
Sentence |
denotes |
Moreover, these changes in CD8 T cell subsets in COVID-19 patients did not show clear correlations with individual metrics of clinical disease such as hsCRP or D-dimer (fig. S2E), although the frequency of KI67+ CD8 T cells associated with IL-6 and ferritin levels. |
T105 |
1530-1689 |
Sentence |
denotes |
Although CD8 T cell activation was common, ~20% of patients had no increase in KI67+ or CD38+HLA-DR+ CD8 T cells above the level found in HD (Fig. 2, E and F). |
T106 |
1690-1915 |
Sentence |
denotes |
Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls. |